Publications by authors named "Grace N Gasser"

Speciation leads to adaptive changes in organ cellular physiology and creates challenges for studying rare cell-type functions that diverge between humans and mice. Rare cystic fibrosis transmembrane conductance regulator (CFTR)-rich pulmonary ionocytes exist throughout the cartilaginous airways of humans, but limited presence and divergent biology in the proximal trachea of mice has prevented the use of traditional transgenic models to elucidate ionocyte functions in the airway. Here we describe the creation and use of conditional genetic ferret models to dissect pulmonary ionocyte biology and function by enabling ionocyte lineage tracing (FOXI1-Cre::ROSA-TG), ionocyte ablation (FOXI1-KO) and ionocyte-specific deletion of CFTR (FOXI1-Cre::CFTR).

View Article and Find Full Text PDF
Article Synopsis
  • CFTR modulator drugs improve lung function and body mass index in cystic fibrosis patients, but inflammation remains a challenge, indicating a need to target the underlying causes in the lungs of patients with established disease.* -
  • The study explores the presence of unique, potentially pathogenic stem cell variants in cystic fibrosis lungs, similar to those found in COPD, and aims to identify which of these variants contribute to ongoing inflammation.* -
  • Research utilized advanced stem cell cloning technology on end-stage CF lungs to identify five predominant stem cell variants, three of which are pro-inflammatory, highlighting the complexity of stem cell involvement in cystic fibrosis lung inflammation.*
View Article and Find Full Text PDF

Pulmonary ionocytes express high levels of cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel that is critical for hydration of the airways and mucociliary clearance. However, the cellular mechanisms that govern ionocyte specification and function remain unclear. We observed that increased abundance of ionocytes in cystic fibrosis (CF) airway epithelium was associated with enhanced expression of Sonic Hedgehog (SHH) effectors.

View Article and Find Full Text PDF

Lentiviral-mediated integration of a transgene cassette into airway basal cells is a strategy being considered for cystic fibrosis (CF) cell-based therapies. However, expression is highly regulated in differentiated airway cell types and a subset of intermediate basal cells destined to differentiate. Since basal stem cells typically do not express CFTR, suppressing the expression from the lentiviral vector in airway basal cells may be beneficial for maintaining their proliferative capacity and multipotency.

View Article and Find Full Text PDF